A marketing authorization application was filed by PTC Therapeutics with the European Medicines Agency seeking the agency's approval for its gene therapy candidate PTC-AADC as a treatment for aromatic l-amino acid decarboxylase deficiency.
PTC seeks EMA's approval for AADC gene therapy candidate
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.